These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17102875)

  • 41. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system.
    Liantonio A; Giannuzzi V; Cippone V; Camerino GM; Pierno S; Camerino DC
    J Pharmacol Exp Ther; 2007 May; 321(2):626-34. PubMed ID: 17293561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ab initio study of hydrogen-bond formation between aliphatic and phenolic hydroxy groups and selected amino acid side chains.
    Nagy PI; Erhardt PW
    J Phys Chem A; 2008 May; 112(18):4342-54. PubMed ID: 18373368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromatography-mass spectrometry methods for the quantitation of statins in biological samples.
    Nirogi R; Mudigonda K; Kandikere V
    J Pharm Biomed Anal; 2007 Jun; 44(2):379-87. PubMed ID: 17433599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression.
    Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A
    Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
    Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
    Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Density functional theory calculations of the internal rotations and vibrational spectra of 2-, 3- and 4-formyl pyridine.
    Umar Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1907-13. PubMed ID: 18799348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylene transfer or carbometalation? A theoretical study to determine the mechanism of lithium carbenoid-promoted cyclopropanation reactions in aggregation and solvation States.
    Ke Z; Zhao C; Phillips DL
    J Org Chem; 2007 Feb; 72(3):848-60. PubMed ID: 17253804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling protein splicing: reaction pathway for C-terminal splice and intein scission.
    Mujika JI; Lopez X; Mulholland AJ
    J Phys Chem B; 2009 Apr; 113(16):5607-16. PubMed ID: 19326906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DFT study of alpha- and beta-D-allopyranose at the B3LYP/6-311++G ** level of theory.
    Schnupf U; Willett JL; Bosma WB; Momany FA
    Carbohydr Res; 2007 Feb; 342(2):196-216. PubMed ID: 17204259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.
    Papadopoulos AG; Sigalas MP
    J Mol Model; 2011 Jul; 17(7):1669-78. PubMed ID: 20981460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
    Yasue H; Mizuno Y; Harada E; Itoh T; Nakagawa H; Nakayama M; Ogawa H; Tayama S; Honda T; Hokimoto S; Ohshima S; Hokamura Y; Kugiyama K; Horie M; Yoshimura M; Harada M; Uemura S; Saito Y;
    J Am Coll Cardiol; 2008 May; 51(18):1742-8. PubMed ID: 18452779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Density-functional theory models of xanthine oxidoreductase activity: comparison of substrate tautomerization and protonation.
    Bayse CA
    Dalton Trans; 2009 Apr; (13):2306-14. PubMed ID: 19290363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissociation of carbonic acid: gas phase energetics and mechanism from ab initio metadynamics simulations.
    Kumar PP; Kalinichev AG; Kirkpatrick RJ
    J Chem Phys; 2007 May; 126(20):204315. PubMed ID: 17552770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level.
    Fujimoto M; Oka T; Murata T; Hori M; Ozaki H
    Eur J Pharmacol; 2009 Jan; 602(2-3):432-8. PubMed ID: 19059394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981.
    Kearney AS; Crawford LF; Mehta SC; Radebaugh GW
    Pharm Res; 1993 Oct; 10(10):1461-5. PubMed ID: 8272408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formation of a Criegee intermediate in the low-temperature oxidation of dimethyl sulfoxide.
    Asatryan R; Bozzelli JW
    Phys Chem Chem Phys; 2008 Apr; 10(13):1769-80. PubMed ID: 18350182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statins (HMG-coenzyme A reductase inhibitors)-biomimetic membrane binding mechanism investigated by molecular chromatography.
    Sarr FS; André C; Guillaume YC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):20-7. PubMed ID: 18479982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydrolysis of a chlorambucil analogue. A DFT study.
    Pineda FP; Ortega-Castro J; Alvarez-Idaboy JR; Frau J; Cabrera BM; Ramírez JC; Donoso J; Muñoz F
    J Phys Chem A; 2011 Mar; 115(11):2359-66. PubMed ID: 21361268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat.
    Zhou R; Xu Q; Zheng P; Yan L; Zheng J; Dai G
    Eur J Pharmacol; 2008 May; 586(1-3):244-50. PubMed ID: 18384769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.